Chow, Laura Q M <br/><br/>
Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Aug 2016 
 - 433-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-016-3098-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Area Under Curve<br/>Drug Interactions<br/>Female<br/>Humans<br/>Incidence<br/>Least-Squares Analysis<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Young Adult<br/>Ramucirumab